Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
1994 2
2002 1
2003 1
2004 2
2005 1
2008 2
2009 1
2010 1
2011 2
2013 1
2014 1
2016 1
2017 1
2018 3
2019 4
2020 3
2021 1
2022 1
2023 3
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

27 results

Results by year

Filters applied: . Clear all
Page 1
Paranasal sinus cancer.
Jégoux F, Métreau A, Louvel G, Bedfert C. Jégoux F, et al. Eur Ann Otorhinolaryngol Head Neck Dis. 2013 Dec;130(6):327-35. doi: 10.1016/j.anorl.2012.07.007. Epub 2013 Mar 21. Eur Ann Otorhinolaryngol Head Neck Dis. 2013. PMID: 23523040 Free article. Review.
A Clinical Study of Maxillary Sinus Squamous Cell Carcinoma.
Kondo A, Kurose M, Obata K, Yamamoto K, Murayama K, Shirasaki H, Himi T. Kondo A, et al. Adv Otorhinolaryngol. 2016;77:83-7. doi: 10.1159/000441879. Epub 2016 Apr 26. Adv Otorhinolaryngol. 2016. PMID: 27115153
We report a retrospective study of 26 patients with maxillary sinus squamous cell carcinoma who were treated at the Sapporo Medical University between January 2002 and December 2008. ...
We report a retrospective study of 26 patients with maxillary sinus squamous cell carcinoma who were trea …
Radiation with concomitant superselective intra-arterial cisplatin infusion for maxillary sinus squamous cell carcinoma.
Ebara T, Ando K, Eishima J, Suzuki M, Kawakami T, Horikoshi H, Tamaki Y. Ebara T, et al. Jpn J Radiol. 2019 Jun;37(6):494-499. doi: 10.1007/s11604-019-00827-1. Epub 2019 Mar 26. Jpn J Radiol. 2019. PMID: 30915648
PURPOSE: To assess the efficacy and prognostic factors after superselective intra-arterial chemoradiation (RADPLAT) for maxillary sinus squamous cell carcinoma (MS-SCC). MATERIALS AND METHODS: Prognostic significance of age, gender, T and N fact …
PURPOSE: To assess the efficacy and prognostic factors after superselective intra-arterial chemoradiation (RADPLAT) for maxillary …
Retrospective analysis of 98 cases of maxillary sinus squamous cell carcinoma and therapeutic exploration.
Wang Y, Yang R, Zhao M, Guo W, Zhang L, Zhang W, Wang X. Wang Y, et al. World J Surg Oncol. 2020 May 6;18(1):90. doi: 10.1186/s12957-020-01862-3. World J Surg Oncol. 2020. PMID: 32375789 Free PMC article.
BACKGROUND: Maxillary sinus squamous cell carcinoma (MSSCC) is a relatively rare head and neck cancer with poorly defined prognosis, and the present study aimed to investigate the outcomes for MSSCC according to different treatments. ...
BACKGROUND: Maxillary sinus squamous cell carcinoma (MSSCC) is a relatively rare head and neck cancer wit …
Therapeutic efficacy of intra-arterial docetaxel and nedaplatin infusion concomitant with radiotherapy for T4 maxillary sinus squamous cell carcinoma.
Heianna J, Makino W, Hirakawa H, Yamashita Y, Tomita H, Murayama S. Heianna J, et al. Int J Oral Maxillofac Surg. 2022 Sep;51(9):1123-1130. doi: 10.1016/j.ijom.2021.12.006. Epub 2021 Dec 24. Int J Oral Maxillofac Surg. 2022. PMID: 34955352
The aim of this study was to evaluate the efficacy of intra-arterial chemoradiotherapy with docetaxel and nedaplatin for T4 maxillary sinus squamous cell carcinoma (MSSCC). Data were retrospectively analysed for 22 consecutive patients with T4 M …
The aim of this study was to evaluate the efficacy of intra-arterial chemoradiotherapy with docetaxel and nedaplatin for T4 maxillary …
Elective management of the N0 neck in maxillary sinus squamous cell carcinoma.
Patel EJ, Strohl MP, Yom SS, El-Sayed I. Patel EJ, et al. Head Neck. 2024 Jan;46(1):171-176. doi: 10.1002/hed.27512. Epub 2023 Nov 5. Head Neck. 2024. PMID: 37927003
OBJECTIVES: To demonstrate adequacy of radiation therapy alone to the neck in patients with maxillary sinus squamous cell carcinoma (MS-SCC) without clinical evidence of regional metastasis. ...
OBJECTIVES: To demonstrate adequacy of radiation therapy alone to the neck in patients with maxillary sinus squamous …
Lymph node metastasis in t4 maxillary sinus squamous cell carcinoma: incidence and treatment outcome.
Homma A, Hayashi R, Matsuura K, Kato K, Kawabata K, Monden N, Hasegawa Y, Onitsuka T, Fujimoto Y, Iwae S, Okami K, Matsuzuka T, Yoshino K, Nibu K, Kato T, Nishino H, Asakage T, Ota I, Kitamura M, Kubota A, Ueda T, Ikebuchi K, Watanabe A, Fujii M. Homma A, et al. Ann Surg Oncol. 2014 May;21(5):1706-10. doi: 10.1245/s10434-014-3544-6. Epub 2014 Feb 20. Ann Surg Oncol. 2014. PMID: 24554063 Free article.
BACKGROUND: The purpose of this study was to evaluate the incidence of lymph node metastasis among patients with T4 maxillary sinus squamous cell carcinoma (MS-SCC) as well as the delayed metastasis rate and the treatment outcome for untreated N …
BACKGROUND: The purpose of this study was to evaluate the incidence of lymph node metastasis among patients with T4 maxillary sinu …
Role of elective neck dissection in prognosis of N0M0 maxillary sinus squamous cell carcinoma: Insights from SEER database analysis.
Li H, Song Y, Zhao L, Liu Y, Liu S. Li H, et al. J Stomatol Oral Maxillofac Surg. 2023 Dec;124(6S):101563. doi: 10.1016/j.jormas.2023.101563. Epub 2023 Jul 15. J Stomatol Oral Maxillofac Surg. 2023. PMID: 37454815
BACKGROUND: The optimal management of cervical lymph nodes in N0M0 maxillary sinus squamous cell carcinoma (MSSCC) remains a subject of debate. ...
BACKGROUND: The optimal management of cervical lymph nodes in N0M0 maxillary sinus squamous cell carcinoma …
A multi-institutional retrospective study of 340 cases of sinonasal malignant tumor.
Tsuji T, Asato R, Kada S, Kitamura M, Tamaki H, Mizuta M, Tanaka S, Watanabe Y, Hori R, Kojima T, Shinohara S, Takebayashi S, Maetani T, Harada H, Kitani Y, Kumabe Y, Tsujimura T, Honda K, Ichimaru K, Ushiro K, Omori K. Tsuji T, et al. Auris Nasus Larynx. 2024 Feb;51(1):86-98. doi: 10.1016/j.anl.2023.05.002. Epub 2023 May 27. Auris Nasus Larynx. 2024. PMID: 37248104
The most common primary site of nasal sinus squamous cell carcinoma is the maxillary sinus. In recent years, a decrease in incidence of maxillary sinus squamous cell carcinoma (MSSCC) has been reported along with a decrease in the incidence of s …
The most common primary site of nasal sinus squamous cell carcinoma is the maxillary sinus. In recent years, a decrease in incidence of m …
27 results